FASN and prostate cancer: Further, in vitro Fasn inactivation by shRNA affects the adhesion, migration, and invasion of prostate cancer cell lines via actin cytoskeletal remodeling, achieved by decreasing the palmitoylation of the GTPase RhoU and consequent inactivation of Cdc42 [34].